May 16th 2024
Research indicates serum LOXL2 levels could serve as a predictor for hepatocellular carcinoma (HCC) risk in HCV patients who have achieved sustained virological response (SVR).
As the Adenovirus-Induced Hepatitis Mystery Continues, an Understanding of Testing is Vital
June 25th 2023Clinicians should consider adenovirus testing in pediatric patients with hepatitis of unknown etiology. Here is an update on the incidence rates and lab diagnostics associated with identifying the virus.
Read More
Working Towards HBV Cure, Company Presents Vaccine Data at Liver Conference
June 22nd 2023Biopharmaceutical company, Vaccitech, has developed its VTP-300 vaccine, and is presenting a poster demonstrating positive early data at the ongoing European Association for the Study of the Liver (EASL) Congress 2023.
Read More
The innovative antibiotic Xacduro has received FDA approval for its efficacy against ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus. The intravenous therapy combines sulbactam and durlobactamto target multidrug-resistant and carbapenem-resistant strains.
Read More
FDA Approves Paxlovid for COVID-19 in Adults, Continues Strategy to Minimize Infection Severity
May 25th 2023This is the first oral antiviral to get through the regulatory process and is indicated for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
Read More
FDA Approves Sulbactam-Durlobactam for Bacterial Pneumonia
May 23rd 2023The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.
Read More
Expanding HCV Care: Effectiveness of Accessible Testing and Treatment for People Who Inject Drugs
May 20th 2023By implementing rapid point-of-care HCV RNA testing in supervised consumption services, a study achieved high testing acceptance and successful engagement with HCV care among individuals who inject drugs.
Read More